Vessel-Sealing Devices Market is expected to reach US$ 3,896.44 million by 2033, at a CAGR of 9% | FMI

 The market share of Vessel-Sealing Devices is estimated to reach US$ 1,645.90 million in 2023 and the market net worth is forecast to reach over US$ US$ 3,896.44 million by 2033. The global vessel-sealing devices market is expected to register a CAGR of 9%. 

Vessel-Sealing Devices Market


Get Complete Access: https://www.futuremarketinsights.com/reports/vessel-sealing-devices-market

It has been found that vessel-sealing devices are more effective in several fields, such as laparoscopic surgery, neck surgery, and axillary dissection. This is expected to drive the vessel-sealing market, which is expected to dominate the healthcare market in the coming years.

With the advancement of surgical devices and increasing FDA approvals for vessel-sealing devices, the market for vessel-sealing devices is expected to grow during the forecast period.

With fewer blood loss complications and less operating time, surgeons have improved safety and efficiency. Technological advancements in surgical devices and FDA guidelines regarding vessel-sealing devices are likely to drive the growth of the market.

Surgical procedures, product developments, and minimally invasive surgery are few of the main drivers of this market.

Key Takeaways:

·         The vessel-sealing devices market is expected to increase at a notable CAGR of 9%

·         North America is a prominent market for vessel-sealing devices and is estimated to expand at a CAGR of 4.5% in the forecast period.

·         The United States is projected to account for 75% of the North American vessel-sealing devices market.

·         Hospitals and specialty clinics are expected to account for a prominent share of the market and rise at a CAGR of 4.86%.

Competitive Landscape

Manufacturers of vessel-sealing devices implement a variety of strategies to meet the needs of domestic and international customers as part of their competitive strategy. To satisfy the needs of domestic and international customers, companies such as Medtronic PLC maintain a steady emphasis on research and development to minimize risk during operations. Furthermore, to gain an advantage over their competition, key players continue to develop products through acquisition, partnerships, and innovation.

Key companies in the market include:

  • Medtronic PLC
  • B Braun Melsungen AG
  • Erbe Medical India Pvt. Ltd
  • Olympus Corporation
  • Ethicon US LLC (Johnson & Johnson)
  • Boston Scientific Corporation
  • BOWA-electronic GmbH & Co. KG
  • OmniGuide Holdings Inc.
  • CONMED Corporation
  • Bolder Surgical Holdings Inc

Recent Developments

·         Olympus Corporation, a Japan-based manufacturer, offers Thunderbeat instrument lineups for endoscopic and open surgery. The device uses ultrasonic energy for fast and precise dissection.

·         In September 2022, Olympus expanded its global footprint with an investment of US$ 34 million in Coimbra, Portugal.

·         Ethicon's Enseal X1 Curved Jaw Tissue Sealer was released in June 2021. This product is used for gynecological, thoracic, bariatric, and colorectal procedures.

·         Bolder Surgical, a developer and manufacturer of energy vessel sealing surgical devices, was acquired by Hologic Inc., a medical technology company, in October 2021 for US$ 160 million, to broaden their surgical portfolio.

To learn more about this report @ https://www.futuremarketinsights.com/reports/vessel-sealing-devices-market

Market Segments Covered in Vessel-Sealing Devices Market Analysis

By Application, the Vessel-sealing Devices Market is Segmented as:

·         General Surgery

·         Laparoscopic Surgery

By End User, the Vessel-sealing Devices Market is Segmented as:

·         Hospitals & Specialty Clinics

·         Ambulatory Surgical Centers

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more

Clostridium Diagnostics Market in US is anticipated to secure a market value worth US$ 2.7 Billion by 2032 | FMI

Image
  The global Clostridium Diagnostics Market is expected to grow at a CAGR of 12.2% during the forecast period, from US$ 2.5 billion in 2022 to US$ 7.8 billion by 2032. The market grew at a CAGR of 13.6% between 2015 and 2021. The rising prevalence of clostridium-related diseases, as well as increased campaigns to educate people about the condition, are driving the market growth. To learn more about this report @ https://www.futuremarketinsights.com/reports/clostridium-diagnostics-market here has been an increased focus of players in the market to offer vaccines, which can augment the market size in the forecast period. For instance, in March 2022, Japan launched a new center, with a budget of US$ 1.6 Billion, to support vaccine and drug projects as a part of a larger scheme to tackle infectious diseases. SCARDA will be in charge of establishing a flagship R&D site for innovative collaborations and controlling funds for R&D projects. Awareness camp...
Read more